Giacchino F, Alloatti S, Quarello F, Bosticardo G M, Giraudo G, Piccoli G
Int J Artif Organs. 1982 Jul;5(4):237-42.
To evaluate the immunological state in chronic renal insufficiency, the Authors studied cellular and humoral immunity in 292 patients with chronic renal failure. They were divided into 3 groups: 1) 37 with creatinine clearance between 50 and 20 ml/min; 2) 57 with creatinine clearance between 20 and 8 ml/min; 3) 178 treated by hemodialysis. In vivo and in vitro tests, that is DNCB, PPD skin tests, spontaneous, active and EAC rosettes, surface membrane immunoglobulin test, complement (C3, C4) and serum immunoglobulins were taken as markers of the immune response. Cell-mediated immunity was found to be significantly impaired in patients with terminal renal insufficiency or on hemodialysis and also markedly reduced in patients with non-terminal renal insufficiency. Humoral immunity produced less significant results: the B lymphocyte count and serum immunoglobulins were normal; only C3 levels were found below normal range. Thus it would seem that cell-mediated immunodeficiency appears in an early stage of chronic renal failure and that hemodialysis does not improve this deficiency.
为评估慢性肾功能不全患者的免疫状态,作者对292例慢性肾衰竭患者的细胞免疫和体液免疫进行了研究。这些患者被分为3组:1)37例肌酐清除率在50至20 ml/分钟之间;2)57例肌酐清除率在20至8 ml/分钟之间;3)178例接受血液透析治疗。采用体内和体外试验,即二硝基氯苯(DNCB)、结核菌素纯蛋白衍生物(PPD)皮肤试验、自发、活性和EAC玫瑰花结试验、表面膜免疫球蛋白试验、补体(C3、C4)和血清免疫球蛋白作为免疫反应的标志物。结果发现,终末期肾功能不全患者或接受血液透析的患者细胞介导免疫显著受损,非终末期肾功能不全患者的细胞介导免疫也明显降低。体液免疫的结果不太显著:B淋巴细胞计数和血清免疫球蛋白正常;仅发现C3水平低于正常范围。因此,似乎细胞介导的免疫缺陷在慢性肾衰竭早期就已出现,且血液透析并不能改善这种缺陷。